Clinical Trial: Evaluating the SUBLOCADE Treatment Exit Strategy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Opioid Use Disorder
Study Type: OBSERVATIONAL
Official Title: A Phase IV Study to Evaluate the SUBLOCADE Treatment Exit Strategy
Brief Summary:
The purpose of this study is to observe and assess the successful taper and opioid withdrawal experience after participants stop receiving SUBLOCADE because their healthcare provider determines their disease symptoms have been controlled for at least 9 months and they, together with their healthcare provider, plan to discontinue MOUD.
Read more